2025 |
Bajaj Finance Ltd.
|
Independent Director |
1.5 Cr |
25.8 % |
2025 |
Bajaj Finserv Ltd.
|
Independent Director |
84 L |
16.7 % |
2025 |
Bajaj Housing Finance Ltd.
|
Independent Director |
81 L |
- |
2025 |
Bajaj Auto Ltd.
|
Independent Director |
66.4 L |
14.3 % |
2024 |
Siemens Ltd.
|
Independent Director |
41.9 L |
- |
2024 |
Bajaj Finance Ltd.
|
Independent Director |
1.2 Cr |
90.5 % |
2024 |
Bajaj Finserv Ltd.
|
Independent Director |
72 L |
166.7 % |
2024 |
Bajaj Auto Ltd.
|
Independent Director |
58.1 L |
18.6 % |
2024 |
Finolex Industries Ltd.
|
Independent Director |
39 L |
21.9 % |
2024 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
24.5 L |
-2.0 % |
2023 |
Bajaj Finance Ltd.
|
Independent Director |
63 L |
-8.7 % |
2023 |
Bajaj Auto Ltd.
|
Independent Director |
49 L |
16.7 % |
2023 |
Finolex Industries Ltd.
|
Independent Director |
32 L |
-50.0 % |
2023 |
Bajaj Finserv Ltd.
|
Independent Director |
27 L |
12.5 % |
2023 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
25 L |
28.2 % |
2023 |
Bajaj Holdings & Investment Ltd.
|
Independent Director |
18 L |
0.0 % |
2022 |
Bajaj Finance Ltd.
|
Independent Director |
69 L |
187.5 % |
2022 |
Finolex Industries Ltd.
|
Non Executive & Independent Director |
64 L |
36.2 % |
2022 |
Bajaj Auto Ltd.
|
Independent Director |
42 L |
- |
2022 |
Bajaj Finserv Ltd.
|
Independent Director |
24 L |
60.0 % |
2022 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
19.5 L |
-9.3 % |
2022 |
Bajaj Holdings & Investment Ltd.
|
Independent Director |
18 L |
- |
2021 |
Finolex Industries Ltd.
|
Non Executive & Independent Director |
47 L |
434.1 % |
2021 |
Bajaj Finance Ltd.
|
Independent Director |
24 L |
14.3 % |
2021 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
21.5 L |
7.5 % |
2021 |
Bajaj Finserv Ltd.
|
Independent Director |
15 L |
0.0 % |
2021 |
Bajaj Auto Ltd.
|
Independent Director |
- |
- |
2021 |
Bajaj Holdings & Investment Ltd.
|
Independent Director |
- |
- |
2020 |
Bajaj Auto Ltd.
|
Independent Director |
24.5 L |
22.5 % |
2020 |
Bajaj Finance Ltd.
|
Independent Director |
21 L |
- |
2020 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
20 L |
0.0 % |
2020 |
Bajaj Holdings & Investment Ltd.
|
Independent Director |
18 L |
- |
2020 |
Bajaj Finserv Ltd.
|
Additional Independent Director |
15 L |
650.0 % |
2020 |
Finolex Industries Ltd.
|
Independent Director |
8.8 L |
- |
2019 |
Bajaj Auto Ltd.
|
Independent Director |
20 L |
33.3 % |
2019 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
20 L |
37.9 % |
2019 |
Bajaj Finserv Ltd.
|
Additional Independent Director |
2 L |
- |
2019 |
Bajaj Finance Ltd.
|
Independent Director |
- |
- |
2019 |
Finolex Industries Ltd.
|
Additional Independent Director |
- |
- |
2019 |
Bajaj Holdings & Investment Ltd.
|
Additional Independent Director |
- |
- |
2018 |
Bajaj Auto Ltd.
|
Independent Director |
15 L |
- |
2018 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
14.5 L |
0.0 % |
2018 |
Bajaj Finserv Ltd.
|
Additional Independent Director |
- |
- |
2018 |
Bajaj Finance Ltd.
|
Independent Director |
- |
- |
2018 |
Bajaj Holdings & Investment Ltd.
|
Additional Independent Director |
- |
- |
2017 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
14.5 L |
29.5 % |
2017 |
Bajaj Auto Ltd.
|
Independent Director |
- |
- |
2016 |
HDFC Bank Ltd.
|
Director |
21 L |
- |
2016 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
11.2 L |
- |